Cargando…

Reduced tricarboxylic acid cycle flux in type 2 diabetes mellitus?

AIMS/HYPOTHESIS: Mitochondrial dysfunction has been postulated to underlie muscular fat accumulation, leading to muscular insulin sensitivity and ultimately type 2 diabetes mellitus. Here we re-interpret previously published data on [(13)C]acetate recovery in breath gas obtained during exercise in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Schrauwen, P., Hesselink, M. K. C.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2516188/
https://www.ncbi.nlm.nih.gov/pubmed/18587560
http://dx.doi.org/10.1007/s00125-008-1069-x
_version_ 1782158461310599168
author Schrauwen, P.
Hesselink, M. K. C.
author_facet Schrauwen, P.
Hesselink, M. K. C.
author_sort Schrauwen, P.
collection PubMed
description AIMS/HYPOTHESIS: Mitochondrial dysfunction has been postulated to underlie muscular fat accumulation, leading to muscular insulin sensitivity and ultimately type 2 diabetes mellitus. Here we re-interpret previously published data on [(13)C]acetate recovery in breath gas obtained during exercise in type 2 diabetic patients and control individuals. METHODS: When infusing [(13)C]palmitate to estimate fat oxidation, part of the label is lost in exchange reactions of the tricarboxylic acid (TCA) cycle. To correct for this loss of label, an acetate recovery factor (ARF) has previously been used, assuming that 100% of the exogenously provided acetate will enter the TCA cycle. The recovery of acetate in breath gas depends on the TCA cycle activity, hence providing an indirect measure of the latter and a marker of mitochondrial function. RESULTS: Re-evaluation of the available literature reveals that the ARF during exercise is highest in lean, healthy individuals, followed by obese individuals and type 2 diabetic patients. CONCLUSIONS/INTERPRETATION: Revisiting previously published findings on the ARF during exercise in type 2 diabetic patients reveals a reduction in muscular TCA cycle flux, reflecting mitochondrial dysfunction, in these patients. How mitochondrial dysfunction is related to type 2 diabetes mellitus—cause or consequence—requires further study.
format Text
id pubmed-2516188
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-25161882008-08-14 Reduced tricarboxylic acid cycle flux in type 2 diabetes mellitus? Schrauwen, P. Hesselink, M. K. C. Diabetologia Short Communication AIMS/HYPOTHESIS: Mitochondrial dysfunction has been postulated to underlie muscular fat accumulation, leading to muscular insulin sensitivity and ultimately type 2 diabetes mellitus. Here we re-interpret previously published data on [(13)C]acetate recovery in breath gas obtained during exercise in type 2 diabetic patients and control individuals. METHODS: When infusing [(13)C]palmitate to estimate fat oxidation, part of the label is lost in exchange reactions of the tricarboxylic acid (TCA) cycle. To correct for this loss of label, an acetate recovery factor (ARF) has previously been used, assuming that 100% of the exogenously provided acetate will enter the TCA cycle. The recovery of acetate in breath gas depends on the TCA cycle activity, hence providing an indirect measure of the latter and a marker of mitochondrial function. RESULTS: Re-evaluation of the available literature reveals that the ARF during exercise is highest in lean, healthy individuals, followed by obese individuals and type 2 diabetic patients. CONCLUSIONS/INTERPRETATION: Revisiting previously published findings on the ARF during exercise in type 2 diabetic patients reveals a reduction in muscular TCA cycle flux, reflecting mitochondrial dysfunction, in these patients. How mitochondrial dysfunction is related to type 2 diabetes mellitus—cause or consequence—requires further study. Springer-Verlag 2008-06-28 2008 /pmc/articles/PMC2516188/ /pubmed/18587560 http://dx.doi.org/10.1007/s00125-008-1069-x Text en © The Author(s) 2008 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Short Communication
Schrauwen, P.
Hesselink, M. K. C.
Reduced tricarboxylic acid cycle flux in type 2 diabetes mellitus?
title Reduced tricarboxylic acid cycle flux in type 2 diabetes mellitus?
title_full Reduced tricarboxylic acid cycle flux in type 2 diabetes mellitus?
title_fullStr Reduced tricarboxylic acid cycle flux in type 2 diabetes mellitus?
title_full_unstemmed Reduced tricarboxylic acid cycle flux in type 2 diabetes mellitus?
title_short Reduced tricarboxylic acid cycle flux in type 2 diabetes mellitus?
title_sort reduced tricarboxylic acid cycle flux in type 2 diabetes mellitus?
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2516188/
https://www.ncbi.nlm.nih.gov/pubmed/18587560
http://dx.doi.org/10.1007/s00125-008-1069-x
work_keys_str_mv AT schrauwenp reducedtricarboxylicacidcyclefluxintype2diabetesmellitus
AT hesselinkmkc reducedtricarboxylicacidcyclefluxintype2diabetesmellitus